300 related articles for article (PubMed ID: 24915543)
21. Metabolic abnormality in the right dorsolateral prefrontal cortex in patients with obsessive-compulsive disorder: proton magnetic resonance spectroscopy.
Park SE; Choi NG; Jeong GW
Acta Neuropsychiatr; 2017 Jun; 29(3):164-169. PubMed ID: 27748207
[TBL] [Abstract][Full Text] [Related]
22. Reduced medial prefrontal N-acetyl-aspartate levels in pediatric major depressive disorder: a multi-voxel in vivo(1)H spectroscopy study.
Olvera RL; Caetano SC; Stanley JA; Chen HH; Nicoletti M; Hatch JP; Fonseca M; Pliszka SR; Soares JC
Psychiatry Res; 2010 Nov; 184(2):71-6. PubMed ID: 20864319
[TBL] [Abstract][Full Text] [Related]
23. Neurobiology of the dorsolateral prefrontal cortex in GAD: Aberrant neurometabolic correlation to hippocampus and relationship to anxiety sensitivity and IQ.
Coplan JD; Webler R; Gopinath S; Abdallah CG; Mathew SJ
J Affect Disord; 2018 Mar; 229():1-13. PubMed ID: 29288871
[TBL] [Abstract][Full Text] [Related]
24. Frontal white matter biochemical abnormalities in first-episode, treatment-naive patients with major depressive disorder: a proton magnetic resonance spectroscopy study.
Wang Y; Jia Y; Xu G; Ling X; Liu S; Huang L
J Affect Disord; 2012 Feb; 136(3):620-6. PubMed ID: 22129769
[TBL] [Abstract][Full Text] [Related]
25. Transcranial magnetic stimulation potentiates glutamatergic neurotransmission in depressed adolescents.
Croarkin PE; Nakonezny PA; Wall CA; Murphy LL; Sampson SM; Frye MA; Port JD
Psychiatry Res Neuroimaging; 2016 Jan; 247():25-33. PubMed ID: 26651598
[TBL] [Abstract][Full Text] [Related]
26. (1)H-magnetic resonance spectroscopy ((1)H-MRS) in methamphetamine dependence and methamphetamine induced psychosis.
Howells FM; Uhlmann A; Temmingh H; Sinclair H; Meintjes E; Wilson D; Stein DJ
Schizophr Res; 2014 Mar; 153(1-3):122-8. PubMed ID: 24529366
[TBL] [Abstract][Full Text] [Related]
27. Measures of Connectivity and Dorsolateral Prefrontal Cortex Volumes and Depressive Symptoms Following Treatment With Selective Serotonin Reuptake Inhibitors in Adolescents.
Lee KH; Shin J; Lee J; Yoo JH; Kim JW; Brent DA
JAMA Netw Open; 2023 Aug; 6(8):e2327331. PubMed ID: 37540512
[TBL] [Abstract][Full Text] [Related]
28. Neurochemical correlates of rapid treatment response to electroconvulsive therapy in patients with major depression.
Njau S; Joshi SH; Espinoza R; Leaver AM; Vasavada M; Marquina A; Woods RP; Narr KL
J Psychiatry Neurosci; 2017 Jan; 42(1):6-16. PubMed ID: 27327561
[TBL] [Abstract][Full Text] [Related]
29. Association between prefrontal glutamine levels and neuroticism determined using proton magnetic resonance spectroscopy.
Hasler G; Buchmann A; Haynes M; Müller ST; Ghisleni C; Brechbühl S; Tuura R
Transl Psychiatry; 2019 Jun; 9(1):170. PubMed ID: 31213596
[TBL] [Abstract][Full Text] [Related]
30. Long-Chain Omega-3 Fatty Acid Supplements in Depressed Heart Failure Patients: Results of the OCEAN Trial.
Jiang W; Whellan DJ; Adams KF; Babyak MA; Boyle SH; Wilson JL; Patel CB; Rogers JG; Harris WS; O'Connor CM
JACC Heart Fail; 2018 Oct; 6(10):833-843. PubMed ID: 30098961
[TBL] [Abstract][Full Text] [Related]
31. Proton magnetic resonance spectroscopic analysis of changes in brain metabolites following electroconvulsive therapy in patients with major depressive disorder.
Tosun Ş; Tosun M; Akansel G; Gökbakan AM; Ünver H; Tural Ü
Int J Psychiatry Clin Pract; 2020 Mar; 24(1):96-101. PubMed ID: 31825726
[No Abstract] [Full Text] [Related]
32. Intermittent theta-burst stimulation moderates interaction between increment of N-Acetyl-Aspartate in anterior cingulate and improvement of unipolar depression.
Zavorotnyy M; Zöllner R; Rekate H; Dietsche P; Bopp M; Sommer J; Meller T; Krug A; Nenadić I
Brain Stimul; 2020; 13(4):943-952. PubMed ID: 32380445
[TBL] [Abstract][Full Text] [Related]
33. Plasma Neuronal and Glial Markers and Anterior Cingulate Metabolite Levels in Major Depressive Disorder: A Pilot Study.
Güleş E; Iosifescu DV; Tural Ü
Neuropsychobiology; 2020; 79(3):214-221. PubMed ID: 32045918
[TBL] [Abstract][Full Text] [Related]
34. Omega 3 polyunsaturated fatty acids and the treatment of depression.
Deacon G; Kettle C; Hayes D; Dennis C; Tucci J
Crit Rev Food Sci Nutr; 2017 Jan; 57(1):212-223. PubMed ID: 25830700
[TBL] [Abstract][Full Text] [Related]
35. Differences in excitatory and inhibitory neurotransmitter levels between depressed patients and healthy controls: A systematic review and meta-analysis.
Godfrey KEM; Gardner AC; Kwon S; Chea W; Muthukumaraswamy SD
J Psychiatr Res; 2018 Oct; 105():33-44. PubMed ID: 30144668
[TBL] [Abstract][Full Text] [Related]
36. Ventromedial prefrontal cortex/anterior cingulate cortex Glx, glutamate, and GABA levels in medication-free major depressive disorder.
Kantrowitz JT; Dong Z; Milak MS; Rashid R; Kegeles LS; Javitt DC; Lieberman JA; John Mann J
Transl Psychiatry; 2021 Aug; 11(1):419. PubMed ID: 34354048
[TBL] [Abstract][Full Text] [Related]
37. Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study.
Auer DP; Pütz B; Kraft E; Lipinski B; Schill J; Holsboer F
Biol Psychiatry; 2000 Feb; 47(4):305-13. PubMed ID: 10686265
[TBL] [Abstract][Full Text] [Related]
38. Proton magnetic resonance spectroscopy in subjects with high genetic risk of schizophrenia: investigation of anterior cingulate, dorsolateral prefrontal cortex and thalamus.
Yoo SY; Yeon S; Choi CH; Kang DH; Lee JM; Shin NY; Jung WH; Choi JS; Jang DP; Kwon JS
Schizophr Res; 2009 Jun; 111(1-3):86-93. PubMed ID: 19406622
[TBL] [Abstract][Full Text] [Related]
39. Improved and residual functional abnormalities in major depressive disorder after electroconvulsive therapy.
Wang J; Ji Y; Li X; He Z; Wei Q; Bai T; Tian Y; Wang K
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jun; 100():109888. PubMed ID: 32061788
[TBL] [Abstract][Full Text] [Related]
40. Antidepressant effect detected on proton magnetic resonance spectroscopy in drug-naïve female patients with first-episode major depression.
Kaymak SU; Demir B; Oğuz KK; Sentürk S; Uluğ B
Psychiatry Clin Neurosci; 2009 Jun; 63(3):350-6. PubMed ID: 19566767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
